Lobbying Filing Details

Total Spending

$680,000

Activities

4

Lobbyists

4

Gov't Entities

16

Filing Information
Filing UUID:
ac8bdfef-e150-469e-98b7-e78a9992b7a1
Type:
Q2 - 2nd Quarter - Report
Period:
2021 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2021 at 8:22 PM
Income:
$0
Expenses:
$680,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Daniel Bachner
Registrant
ABBVIE, INC.

Biopharmaceutical company

Washington, District of Columbia
Client
ABBVIE INC.
District of Columbia, United States of America
Lobbying Activities (4)
Activity 1
Copyright/Patent/Trademark

Patent litigation reform issues and issues related to post-grant proceedings at the USPTO
Value of intellectual property

Lobbyists (4)
  • STEPHEN SCANGO
  • DANIEL BACHNER
  • DORCAS ADEKUNLE
  • CRYSTAL RILEY
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Treasury, Dept of
Activity 2
Health Issues

H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act
H.R. 19, Lower Costs, More Cures Act
S. 2164, Lower Costs, More Cures Act of 2021
Drug cost and pricing policy issues
Patient affordability issues
Policy proposals relating to clinical trial diversity
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021 & 2022; Notice Requirement for Non-Federal Governmental Plans proposed rule

Lobbyists (4)
  • STEPHEN SCANGO
  • DANIEL BACHNER
  • DORCAS ADEKUNLE
  • CRYSTAL RILEY
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Treasury, Dept of
Activity 3
Medicare/Medicaid

Policy Proposals related to Medicare Part D and patient cost-sharing
Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues
Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements (CMS 2482-F)

Lobbyists (4)
  • STEPHEN SCANGO
  • DANIEL BACHNER
  • DORCAS ADEKUNLE
  • CRYSTAL RILEY
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Treasury, Dept of
Activity 4
Taxation/Internal Revenue Code

Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation
Policy proposals relating to economic activity in Puerto Rico
International tax issues, including OECD digital taxation work program

Lobbyists (4)
  • STEPHEN SCANGO
  • DANIEL BACHNER
  • DORCAS ADEKUNLE
  • CRYSTAL RILEY
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Treasury, Dept of

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.